Skip to content

Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis

Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06267365
Enrollment
100
Registered
2024-02-20
Start date
2023-11-27
Completion date
2028-06-01
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pancreatitis

Brief summary

This is an observational prospective study to develop predictive biomarkers for pain response in participants with chronic pancreatitis scheduled for endoscopic therapy. Participants will undergo baseline assessments including electroencephalography (EEG), quantitative sensory testing (QST), and psychosocial questionnaires. Response to endoscopic therapy will be assessed at approximately 3, 6, 12 and 18 months post-procedure using questionnaires.

Interventions

None listed

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS)
CollaboratorNIH
NYU Langone Health
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adults older than 18 years; * Cambridge III or IV criteria for Chronic Pancreatitis (CP); or M-ANNHEIM criteria for definitive chronic pancreatitis; * scheduled for endoscopic therapy for ductal obstruction (may include lithotripsy, pancreatic duct dilation, or stone extraction to facilitate successful stenting) as part of routine clinical care based on multidisciplinary review; * pain present for ≥ 3 days per week for ≥ 3 months; * average pain over the last week ≥ 4 on a 11-point numeric rating scale (NRS).

Exclusion criteria

* chronic pain syndrome other than CP; * episode of acute pancreatitis within 2 months of enrollment; * endoscopic therapy including Endoscopic retrograde cholangiopancreatography (ERCP), Endoscopic ultrasound (EUS) Guided Celiac Plexus Block or pancreatic surgery \< 6 months prior to enrollment; * active illicit drug use (excludes marijuana use); * American Society of Anesthesiologists classification \> 3; * immune-mediated pancreatitis or associated pancreatic neoplasms * Major neurological disease such as stroke, uncontrolled epilepsy, dementia * Diagnosis of schizophrenia * Chronic benzodiazepine use. Use of short acting benzodiazepine on as needed basis is acceptable if participant is able to hold benzodiazepine prior to EEG recording. * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in Brief Pain Inventory (BPI) Score at Month 3 Post-OperationBaseline, Month 3 Post-OperationBPI is a 9-item assessment of pain. Each item is rated on a Likert scale from 0 (No Pain) to 10 (Pain as bad as you can imagine). The total score is the sum of responses and ranges from 0-90; higher scores indicate greater pain.

Secondary

MeasureTime frameDescription
Change from Baseline in BPI Score at Month 12 Post-OperationBaseline, Month 12 Post-OperationBPI is a 9-item assessment of pain. Each item is rated on a Likert scale from 0 (No Pain) to 10 (Pain as bad as you can imagine). The total score is the sum of responses and ranges from 0-90; higher scores indicate greater pain.
Change from Baseline in BPI Score at Month 18 Post-OperationBaseline, Month 18 Post-OperationBPI is a 9-item assessment of pain. Each item is rated on a Likert scale from 0 (No Pain) to 10 (Pain as bad as you can imagine). The total score is the sum of responses and ranges from 0-90; higher scores indicate greater pain.
Change from Baseline in Patient Reported Outcome System (PROMIS) - Physical Function - Short Form 6b Score at Month 3 Post-OperationBaseline, Month 3 Post-OperationThe PROMIS Physical Function Short Form 6b comprises 6 questions assessing general physical function. Each item is rated on a Likert scale from 1 (Unable to do) to 5 (Without any difficulty). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater physical function.
Change from Baseline in PROMIS - Physical Function - Short Form 6b Score at Month 6 Post-OperationBaseline, Month 6 Post-OperationThe PROMIS Physical Function Short Form 6b comprises 6 questions assessing general physical function. Each item is rated on a Likert scale from 1 (Unable to do) to 5 (Without any difficulty). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater physical function.
Change from Baseline in PROMIS - Physical Function - Short Form 6b Score at Month 12 Post-OperationBaseline, Month 12 Post-OperationThe PROMIS Physical Function Short Form 6b comprises 6 questions assessing general physical function. Each item is rated on a Likert scale from 1 (Unable to do) to 5 (Without any difficulty). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater physical function.
Change from Baseline in PROMIS - Physical Function - Short Form 6b Score at Month 18 Post-OperationBaseline, Month 18 Post-OperationThe PROMIS Physical Function Short Form 6b comprises 6 questions assessing general physical function. Each item is rated on a Likert scale from 1 (Unable to do) to 5 (Without any difficulty). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater physical function.
Number of Participants who use Opioids at BaselineBaseline
Number of Participants who use Opioids at Month 3Month 3
Number of Participants who use Opioids at Month 6Month 6
Number of Participants who use Opioids at Month 12Month 12
Number of Participants who use Opioids at Month 18Month 18
Change from Baseline in PROMIS - Depression - Short Form 4a Score at Month 3 Post-ProcedureBaseline, Month 3 Post-ProcedureThe PROMIS Depression - Short Form 4a is a 4-item assessment of symptoms of depression in the past 7 days. Items are ranked on a Likert scale from 1 (never) to 5 (always). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of depressive symptoms.
Change from Baseline in PROMIS - Depression - Short Form 4a Score at Month 6 Post-ProcedureBaseline, Month 6 Post-ProcedureThe PROMIS Depression - Short Form 4a is a 4-item assessment of symptoms of depression in the past 7 days. Items are ranked on a Likert scale from 1 (never) to 5 (always). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of depressive symptoms.
Change from Baseline in PROMIS - Depression - Short Form 4a Score at Month 12 Post-ProcedureBaseline, Month 12 Post-ProcedureThe PROMIS Depression - Short Form 4a is a 4-item assessment of symptoms of depression in the past 7 days. Items are ranked on a Likert scale from 1 (never) to 5 (always). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of depressive symptoms.
Change from Baseline in PROMIS - Depression - Short Form 4a Score at Month 18 Post-ProcedureBaseline, Month 18 Post-ProcedureThe PROMIS Depression - Short Form 4a is a 4-item assessment of symptoms of depression in the past 7 days. Items are ranked on a Likert scale from 1 (never) to 5 (always). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of depressive symptoms.
Change from Baseline in PROMIS - Anxiety- Short Form 4a Score at Month 3 Post-ProcedureBaseline, Month 3 Post-ProcedureThe PROMIS Anxiety- Short Form 4a is a 4-item assessment of symptoms of anxiety in the past 7 days. Items are ranked on a Likert scale from 1 (never) to 5 (always). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of anxiety.
Change from Baseline in PROMIS - Anxiety- Short Form 4a Score at Month 6 Post-ProcedureBaseline, Month 6 Post-ProcedureThe PROMIS Anxiety- Short Form 4a is a 4-item assessment of symptoms of anxiety in the past 7 days. Items are ranked on a Likert scale from 1 (never) to 5 (always). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of anxiety.
Change from Baseline in PROMIS - Anxiety- Short Form 4a Score at Month 12 Post-ProcedureBaseline, Month 12 Post-ProcedureThe PROMIS Anxiety- Short Form 4a is a 4-item assessment of symptoms of anxiety in the past 7 days. Items are ranked on a Likert scale from 1 (never) to 5 (always). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of anxiety.
Change from Baseline in PROMIS - Anxiety- Short Form 4a Score at Month 18 Post-ProcedureBaseline, Month 18 Post-ProcedureThe PROMIS Anxiety- Short Form 4a is a 4-item assessment of symptoms of anxiety in the past 7 days. Items are ranked on a Likert scale from 1 (never) to 5 (always). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of anxiety.
Change from Baseline in PROMIS - Neuropathic Pain Quality 5a Score at Month 3 Post-ProcedureBaseline, Month 3 Post-ProcedureThe PROMIS Neuropathic Pain Quality 5a is a 5-item assessment of symptoms of neuropathic pain in the past 7 days. Items are ranked on a Likert scale from 1 (not at all) to 5 (very much). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of neuropathic pain.
Change from Baseline in PROMIS - Neuropathic Pain Quality 5a Score at Month 6 Post-ProcedureBaseline, Month 6 Post-ProcedureThe PROMIS Neuropathic Pain Quality 5a is a 5-item assessment of symptoms of neuropathic pain in the past 7 days. Items are ranked on a Likert scale from 1 (not at all) to 5 (very much). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of neuropathic pain.
Change from Baseline in PROMIS - Neuropathic Pain Quality 5a Score at Month 12 Post-ProcedureBaseline, Month 12 Post-ProcedureThe PROMIS Neuropathic Pain Quality 5a is a 5-item assessment of symptoms of neuropathic pain in the past 7 days. Items are ranked on a Likert scale from 1 (not at all) to 5 (very much). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of neuropathic pain.
Change from Baseline in PROMIS - Neuropathic Pain Quality 5a Score at Month 18 Post-ProcedureBaseline, Month 18 Post-ProcedureThe PROMIS Neuropathic Pain Quality 5a is a 5-item assessment of symptoms of neuropathic pain in the past 7 days. Items are ranked on a Likert scale from 1 (not at all) to 5 (very much). The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of neuropathic pain.
Change from Baseline in PROMIS - Sleep Disturbance - Short Form 6a Score at Month 3 Post-ProcedureBaseline, Month 3 Post-ProcedureThe PROMIS Sleep Disturbance - Short Form 6a is a 6-item assessment of sleep disturbance in the past 7 days. Items are ranked on a Likert scale from 1-5. The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of sleep disturbance.
Change from Baseline in PROMIS - Sleep Disturbance - Short Form 6a Score at Month 6 Post-ProcedureBaseline, Month 6 Post-ProcedureThe PROMIS Sleep Disturbance - Short Form 6a is a 6-item assessment of sleep disturbance in the past 7 days. Items are ranked on a Likert scale from 1-5. The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of sleep disturbance.
Change from Baseline in PROMIS - Sleep Disturbance - Short Form 6a Score at Month 12 Post-ProcedureBaseline, Month 12 Post-ProcedureThe PROMIS Sleep Disturbance - Short Form 6a is a 6-item assessment of sleep disturbance in the past 7 days. Items are ranked on a Likert scale from 1-5. The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of sleep disturbance.
Change from Baseline in PROMIS - Sleep Disturbance - Short Form 6a Score at Month 18 Post-ProcedureBaseline, Month 18 Post-ProcedureThe PROMIS Sleep Disturbance - Short Form 6a is a 6-item assessment of sleep disturbance in the past 7 days. Items are ranked on a Likert scale from 1-5. The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of sleep disturbance.
Change from Baseline in PROMIS - Fatigue - Short Form 6a Score at Month 3 Post-ProcedureBaseline, Month 3 Post-ProcedureThe PROMIS Fatigue - Short Form 6a is a 6-item assessment of fatigue in the past 7 days. Items are ranked on a Likert scale from 1-5. The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of fatigue.
Change from Baseline in PROMIS - Fatigue - Short Form 6a Score at Month 6 Post-ProcedureBaseline, Month 6 Post-ProcedureThe PROMIS Fatigue - Short Form 6a is a 6-item assessment of fatigue in the past 7 days. Items are ranked on a Likert scale from 1-5. The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of fatigue.
Change from Baseline in PROMIS - Fatigue - Short Form 6a Score at Month 12 Post-ProcedureBaseline, Month 12 Post-ProcedureThe PROMIS Fatigue - Short Form 6a is a 6-item assessment of fatigue in the past 7 days. Items are ranked on a Likert scale from 1-5. The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of fatigue.
Change from Baseline in PROMIS - Fatigue - Short Form 6a Score at Month 18 Post-ProcedureBaseline, Month 18 Post-ProcedureThe PROMIS Fatigue - Short Form 6a is a 6-item assessment of fatigue in the past 7 days. Items are ranked on a Likert scale from 1-5. The raw score is the sum of responses and is transformed into a T-score a mean of 50 and standard deviation of 10. Scores range from 0-100; higher scores indicate greater prevalence of fatigue.
Change from Baseline in Pain Catastrophizing Scale (PCS) Score at Month 3 Post-ProcedureBaseline, Month 3 Post-ProcedureThe PCS is a 13-item assessment of the prevalence of thoughts and feelings associated with pain. Each item is rated on a Likert scale from 0 (not at all) to 4 (all the time). The total score is the sum of responses and ranges from 0 to 52; higher scores indicate greater pain catastrophizing.
Change from Baseline in PCS Score at Month 6 Post-ProcedureBaseline, Month 6 Post-ProcedureThe PCS is a 13-item assessment of the prevalence of thoughts and feelings associated with pain. Each item is rated on a Likert scale from 0 (not at all) to 4 (all the time). The total score is the sum of responses and ranges from 0 to 52; higher scores indicate greater pain catastrophizing.
Change from Baseline in PCS Score at Month 12 Post-ProcedureBaseline, Month 12 Post-ProcedureThe PCS is a 13-item assessment of the prevalence of thoughts and feelings associated with pain. Each item is rated on a Likert scale from 0 (not at all) to 4 (all the time). The total score is the sum of responses and ranges from 0 to 52; higher scores indicate greater pain catastrophizing.
Change from Baseline in PCS Score at Month 18 Post-ProcedureBaseline, Month 18 Post-ProcedureThe PCS is a 13-item assessment of the prevalence of thoughts and feelings associated with pain. Each item is rated on a Likert scale from 0 (not at all) to 4 (all the time). The total score is the sum of responses and ranges from 0 to 52; higher scores indicate greater pain catastrophizing.
Change from Baseline in Sleep Duration at Month 3 Post-ProcedureBaseline, Month 3 Post-Procedure
Change from Baseline in Sleep Duration at Month 6 Post-ProcedureBaseline, Month 6 Post-Procedure
Change from Baseline in Sleep Duration at Month 12 Post-ProcedureBaseline, Month 12 Post-Procedure
Change from Baseline in Sleep Duration at Month 18 Post-ProcedureBaseline, Month 18 Post-Procedure
Change from Baseline in Tobacco, Alcohol, Prescription medications, and other Substance (TAPS) Score at Month 3 Post-ProcedureBaseline, Month 3 Post-ProcedureTAPS consists of a combined screening component (TAPS-1) followed by a brief followed by a brief assessment (TAPS-2) for those who screen positive. Scores on these questions generate a risk level per substance endorsed, based on a range of possible scores per substance. Scores range from 0-4; higher scores indicate a higher likelihood of problematic substance use.
Change from Baseline in TAPS Score at Month 6 Post-ProcedureBaseline, Month 6 Post-ProcedureTAPS consists of a combined screening component (TAPS-1) followed by a brief followed by a brief assessment (TAPS-2) for those who screen positive. Scores on these questions generate a risk level per substance endorsed, based on a range of possible scores per substance. Scores range from 0-4; higher scores indicate a higher likelihood of problematic substance use.
Change from Baseline in TAPS Score at Month 12 Post-ProcedureBaseline, Month 12 Post-ProcedureTAPS consists of a combined screening component (TAPS-1) followed by a brief followed by a brief assessment (TAPS-2) for those who screen positive. Scores on these questions generate a risk level per substance endorsed, based on a range of possible scores per substance. Scores range from 0-4; higher scores indicate a higher likelihood of problematic substance use.
Change from Baseline in TAPS Score at Month 18 Post-ProcedureBaseline, Month 18 Post-ProcedureTAPS consists of a combined screening component (TAPS-1) followed by a brief followed by a brief assessment (TAPS-2) for those who screen positive. Scores on these questions generate a risk level per substance endorsed, based on a range of possible scores per substance. Scores range from 0-4; higher scores indicate a higher likelihood of problematic substance use.
Change from Baseline in Patient Global Impression of Change (PGIC) Score at Month 3 Post-ProcedureBaseline, Month 3 Post-ProcedurePGIC is a 1-item assessment of patient's perception of the change in activity limitation, symptoms, emotions and overall quality of life related to their condition since beginning treatment. The item is rated on a scale from 1 (no change) to 7 (a great deal better). The final score is the numerical rating; higher scores indicate greater change.
Change from Baseline in PGIC Score at Month 6 Post-ProcedureBaseline, Month 6 Post-ProcedurePGIC is a 1-item assessment of patient's perception of the change in activity limitation, symptoms, emotions and overall quality of life related to their condition since beginning treatment. The item is rated on a scale from 1 (no change) to 7 (a great deal better). The final score is the numerical rating; higher scores indicate greater change.
Change from Baseline in PGIC Score at Month 12 Post-ProcedureBaseline, Month 12 Post-ProcedurePGIC is a 1-item assessment of patient's perception of the change in activity limitation, symptoms, emotions and overall quality of life related to their condition since beginning treatment. The item is rated on a scale from 1 (no change) to 7 (a great deal better). The final score is the numerical rating; higher scores indicate greater change.
Change from Baseline in PGIC Score at Month 18 Post-ProcedureBaseline, Month 18 Post-ProcedurePGIC is a 1-item assessment of patient's perception of the change in activity limitation, symptoms, emotions and overall quality of life related to their condition since beginning treatment. The item is rated on a scale from 1 (no change) to 7 (a great deal better). The final score is the numerical rating; higher scores indicate greater change.
Change from Baseline in Patient Health Questionnaire-2 (PHQ-2) Score at Month 3 Post-ProcedureBaseline, Month 3 Post-ProcedurePHQ-2 is a 2-item assessment of patient health in the last 2 weeks. Items are rated on a Likert scale from 0 (not at all) to 3 (nearly every day). The total score is the sum of responses and ranges from 0 to 6; lower scores indicate better health.
Change from Baseline in PHQ-2 Score at Month 6 Post-ProcedureBaseline, Month 6 Post-ProcedurePHQ-2 is a 2-item assessment of patient health in the last 2 weeks. Items are rated on a Likert scale from 0 (not at all) to 3 (nearly every day). The total score is the sum of responses and ranges from 0 to 6; lower scores indicate better health.
Change from Baseline in PHQ-2 Score at Month 12 Post-ProcedureBaseline, Month 12 Post-ProcedurePHQ-2 is a 2-item assessment of patient health in the last 2 weeks. Items are rated on a Likert scale from 0 (not at all) to 3 (nearly every day). The total score is the sum of responses and ranges from 0 to 6; lower scores indicate better health.
Change from Baseline in PHQ-2 Score at Month 18 Post-ProcedureBaseline, Month 18 Post-ProcedurePHQ-2 is a 2-item assessment of patient health in the last 2 weeks. Items are rated on a Likert scale from 0 (not at all) to 3 (nearly every day). The total score is the sum of responses and ranges from 0 to 6; lower scores indicate better health.
Change from Baseline in Generalized Anxiety Disorder 2 (GAD-2) Score at Month 3 Post-ProcedureBaseline, Month 3 Post-ProcedureGAD-2 is a 2-item assessment of symptoms of anxiety in the past two weeks. Items are rated on a Likert scale from 0 (not at all) to 3 (nearly every day).The total score is the sum of responses and ranges from 0-6; higher scores indicate greater symptoms of anxiety.
Change from Baseline in BPI Score at Month 6 Post-OperationBaseline, Month 6 Post-OperationBPI is a 9-item assessment of pain. Each item is rated on a Likert scale from 0 (No Pain) to 10 (Pain as bad as you can imagine). The total score is the sum of responses and ranges from 0-90; higher scores indicate greater pain.
Change from Baseline in GAD-2 Score at Month 12 Post-ProcedureBaseline, Month 12 Post-ProcedureGAD-2 is a 2-item assessment of symptoms of anxiety in the past two weeks. Items are rated on a Likert scale from 0 (not at all) to 3 (nearly every day).The total score is the sum of responses and ranges from 0-6; higher scores indicate greater symptoms of anxiety.
Change from Baseline in GAD-2 Score at Month 18 Post-ProcedureBaseline, Month 18 Post-ProcedureGAD-2 is a 2-item assessment of symptoms of anxiety in the past two weeks. Items are rated on a Likert scale from 0 (not at all) to 3 (nearly every day).The total score is the sum of responses and ranges from 0-6; higher scores indicate greater symptoms of anxiety.
Change from Baseline in Pain, Enjoyment of Life and General Activity (PEG) Scale at Month 3 Post-ProcedureBaseline, Month 3 Post-ProcedurePEG is a 3-item assessment of pain and how it interferes with activities of daily life. Each item is rated on a scale from 0 (does not interfere) to 10 (completely interferes). The total score is the average of the 3 items and ranges from 0-10; higher scores indicate greater pain interference.
Change from Baseline in PEG Scale at Month 6 Post-ProcedureBaseline, Month 6 Post-ProcedurePEG is a 3-item assessment of pain and how it interferes with activities of daily life. Each item is rated on a scale from 0 (does not interfere) to 10 (completely interferes). The total score is the average of the 3 items and ranges from 0-10; higher scores indicate greater pain interference.
Change from Baseline in PEG Scale at Month 12 Post-ProcedureBaseline, Month 12 Post-ProcedurePEG is a 3-item assessment of pain and how it interferes with activities of daily life. Each item is rated on a scale from 0 (does not interfere) to 10 (completely interferes). The total score is the average of the 3 items and ranges from 0-10; higher scores indicate greater pain interference.
Change from Baseline in PEG Scale at Month 18 Post-ProcedureBaseline, Month 18 Post-ProcedurePEG is a 3-item assessment of pain and how it interferes with activities of daily life. Each item is rated on a scale from 0 (does not interfere) to 10 (completely interferes). The total score is the average of the 3 items and ranges from 0-10; higher scores indicate greater pain interference.
Change from Baseline in GAD-2 Score at Month 6 Post-ProcedureBaseline, Month 6 Post-ProcedureGAD-2 is a 2-item assessment of symptoms of anxiety in the past two weeks. Items are rated on a Likert scale from 0 (not at all) to 3 (nearly every day).The total score is the sum of responses and ranges from 0-6; higher scores indicate greater symptoms of anxiety.

Countries

United States

Contacts

Primary ContactLisa Doan, MD
Lisa.doan@nyulangone.org212-263-5072

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026